Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 clinical trials

Explore recruiting myotonic dystrophy type 1 and type 2 dm1 dm2 clinical trials.

Recruiting myotonic dystrophy type 1 and type 2 dm1 dm2 studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients with Myotonic Dystrophy Type 1 and Type 2 who have completed the MEX-DM-302 Study.

Belgium, Italy, Germany, Denmark, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Once Daily Mexiletine PR During 26 Weeks of Treatment in Patients with Myotonic Dystrophy Type 1 and Type 2

Germany, Denmark, Italy, Belgium, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 trials by city

Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Toronto Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Vancouver Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Montreal Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Calgary Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Edmonton Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Ottawa Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Winnipeg Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Quebec City Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Hamilton Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Kitchener Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in London Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Halifax Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in New York Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Los Angeles Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Chicago Myotonic Dystrophy Type 1 And Type 2 Dm1 Dm2 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease